CLDX (Celldex Therapeutics) Pangali Forward P/E

Logo korporat perusahaan Celldex (CLDX)

The 12-month forward P/E for Celldex Therapeutics (CLDX) is recorded at 0.00 on this GURU.Markets platform chart. The asset's price action remains independent of macroeconomic trends, reacting solely to scientific reports and the risk of secondary offerings. Investor confidence rests on the authority of Celldex Therapeutics (CLDX) in developing targeted antibodies, while the strategy focuses on expanding clinical trials to attract global partners.

Prakiraan rega marang bathi: Celldex Therapeutics, Inc. (CLDX) kanggo 04.07.2022 - 11.11.2026

Rincian analitis perusahaan Celldex Therapeutics

Ringkesan analitik perusahaan:Celldex Therapeutics, Inc.
Sampel barang Celldex Therapeutics

Investors often face a choice between current undervaluation and future growth potential. By analyzing the forward P/E chart for Celldex Therapeutics (CLDX), one can assess the relationship between market value and projected earnings. This ratio reflects market expectations regarding the pace of asset monetization. For Celldex Therapeutics (CLDX), this metric correlates directly with successes in the development of targeted antibodies. A high multiple here confirms the market's belief in the technological superiority of the R&D sector.

Pesaing Celldex Therapeutics (CLDX)

Prakiraan rega marang bathi ARGX (argenx)|BNTX (BioNTech Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ABVX (abivax.com)|Kapitalisasi marang proyeksi bathi ADMA Corp (ADMA)|PTGX - Rega marang bathi mangsa ngarep|immunovant.com (IMVT) - Prakiraan rega marang bathi|Kiniksa (KNSA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Grifols SA|Prakiraan rega marang bathi ADPT|Pangali Forward P/E Aurinia Corp|Rega marang bathi mangsa ngarep BioCryst (BCRX)|veratx.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Rasio prakiraan rega marang bathi|AbCellera Bio - Pangali Forward P/E|Tourmaline (TRML) - Prakiraan rega marang bathi|PGEN: Pangali Forward P/E|Rasio prakiraan rega marang bathi pharming.com (PHAR)|Rega marang bathi mangsa ngarep Nektar Therapeutics Inc.|Rega marang bathi mangsa ngarep UPB|Rega marang bathi mangsa ngarep Zenas Biopharma, Inc. (ZBIO)|Rega marang bathi mangsa ngarep IMNM (Immunome Bio)|Pangali Forward P/E GOSS (Gossamer Bio, Inc.)|KALV: Rasio rega marang bathi mangsa ngarep|Septerna - Pangali Forward P/E|Rasio prakiraan rega marang bathi Pieris Pharma|SVRA (Savara Corp) - Prakiraan rega marang bathi|Rasio rega marang bathi mangsa ngarep RIGL|Prakiraan rega marang bathi ANAB|ATXS: Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi ENGN (enGene)|Rasio kapitalisasi marang bathi mangsa ngarep RAPT|Pangali Forward P/E JBIO (Aerovate Therapeutics)|Pangali mangsa ngarep rega marang bathi ACRS|Kyverna Therapeutics - Pangali Forward P/E|Rasio prakiraan rega marang bathi tizianalifesciences.com|Cabaletta Bio (CABA) - Rega marang bathi mangsa ngarep|Ventyx Biosciences Inc. - Pangali mangsa ngarep rega marang bathi|THTX (Theratechnologies Inc) - Pangali Forward P/E|Pangali Forward P/E Avalo Therapeutics Inc|Rega marang bathi mangsa ngarep Eledon Pharmaceuticals (ELDN)|AGEN: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E CLYM (Climb Bio)|Zura Bio Ltd (ZURA) - Rasio prakiraan rega marang bathi|ATYR: Prakiraan rega marang bathi|ADAG - Pangali Forward P/E|IMA (ikenaoncology.com) - Prakiraan rega marang bathi|STTK: Rasio kapitalisasi marang bathi mangsa ngarep|EQ (Equillium Inc) - Pangali Forward P/E|Connect Pharma (CNTB) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E IMUX|Prakiraan rega marang bathi atarabio.com ATRA|Rega marang bathi mangsa ngarep InflaRx IFRX|Kapitalisasi marang proyeksi bathi x4pharma.com (XFOR)|Adicet - Pangali Forward P/E|Celularity Inc. (CELU) - Prakiraan rega marang bathi|INmune Bio Corp (INMB) - Rega marang bathi mangsa ngarep|BRNS (Barinthus Biotherapeutics Corp) - Rega marang bathi mangsa ngarep|KZR (Kezar Life Sciences) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep SABS (sabbiotherapeutics.com)|Prakiraan rega marang bathi AKTX (Akari Therapeutics Plc)|enlivex.com - Rasio rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Q32 Bio QTTB|GOVX (GeoVax Corp) - Rasio rega marang bathi sing dikarepake|Edesa Biotech, Inc. - Pangali Forward P/E|Pangali mangsa ngarep rega marang bathi IBIO (ibioinc.com)|CARM: Pangali Forward P/E|XTL Biopharmaceuticals Ltd (XTLB) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Bolt Biotherapeutics Inc.|HCWB: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Aptevo Therapeutics (APVO)|Prakiraan rega marang bathi AIM ImmunoTech, Inc. AIM|Pangali Forward P/E ADTX (Aditxt, Inc.)|Pangali Forward P/E GRI Bio Inc GRI|XRTX: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi HIND (Vyome Therapeutics)|REVB: Pangali Forward P/E|INDP - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Scinai Immunotherapeutics Ltd.|Prakiraan rega marang bathi CalciMedica Corp (CALI)|Rega marang bathi mangsa ngarep Affimed (AFMD)|Prakiraan rega marang bathi allakos.com ALLK|HOOKIPA Pharma - Prakiraan rega marang bathi|Pangali Forward P/E IGM Biosciences Inc. IGMS|ITOS - Rega marang bathi mangsa ngarep|OCEA (Ocean Biomedical Inc) - Rasio rega marang bathi mangsa ngarep|TCBP: Pangali Forward P/E|Rasio prakiraan rega marang bathi Third Harmonic Bio Inc (THRD)